sarpogrelate has been researched along with Cardiovascular Diseases in 4 studies
sarpogrelate: structure given in first source
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarpogrelate has been found to have beneficial effects in peripheral vascular disease, restenosis after coronary stenting, pulmonary hypertension, acute and chronic myocardial infarction." | 2.42 | Therapeutic potentials of sarpogrelate in cardiovascular disease. ( Arneja, AS; Dhalla, NS; Goyal, RK; Kumamoto, H; Saini, HK; Takeda, N, 2004) |
| "Sarpogrelate is a selective 5-hydroxytryptamine receptor subtype 2A (5-HT2A) antagonist." | 2.42 | Sarpogrelate: cardiovascular and renal clinical potential. ( Doggrell, SA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marcinkowska, M | 1 |
| Kubacka, M | 1 |
| Zagorska, A | 1 |
| Jaromin, A | 1 |
| Fajkis-Zajaczkowska, N | 1 |
| Kolaczkowski, M | 1 |
| Higashi, Y | 1 |
| Fujita, M | 1 |
| Origasa, H | 1 |
| Miyata, T | 1 |
| Matsuo, H | 1 |
| Naritomi, H | 1 |
| Shigematsu, H | 1 |
| Saini, HK | 1 |
| Takeda, N | 1 |
| Goyal, RK | 1 |
| Kumamoto, H | 1 |
| Arneja, AS | 1 |
| Dhalla, NS | 1 |
| Doggrell, SA | 1 |
2 reviews available for sarpogrelate and Cardiovascular Diseases
| Article | Year |
|---|---|
Therapeutic potentials of sarpogrelate in cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Sero | 2004 |
Sarpogrelate: cardiovascular and renal clinical potential.
Topics: Animals; Cardiovascular Diseases; Humans; Kidney Diseases; Molecular Structure; Succinates | 2004 |
2 other studies available for sarpogrelate and Cardiovascular Diseases
| Article | Year |
|---|---|
Exploring the antiplatelet activity of serotonin 5-HT
Topics: Animals; Cardiovascular Diseases; Humans; Isoxazoles; Male; Platelet Aggregation; Platelet Aggregati | 2022 |
Study design of SEASON registry: prospective Surveillance of cardiovascular Events in an Antiplatelet-treated arterioSclerosis Obliterans patients in JapaN )SEASON).
Topics: Arteriosclerosis Obliterans; Cardiovascular Diseases; Humans; Japan; Platelet Aggregation Inhibitors | 2010 |